Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	5.18B
Revenue (ttm)	6.75B
Net Income (ttm)	364.62M
Shares Out	85.00M
EPS (ttm)	4.29
PE Ratio	14.20
Forward PE	12.61
Dividend	1.89 (3.13%)
Ex-Dividend Date	Nov 10, 2025

Volume	93,851
Average Volume	165,821
Open	60.10
Previous Close	60.20
Day's Range	60.10 - 61.20
52-Week Range	60.05 - 87.30
Beta	0.06
RSI	33.26
Earnings Date	Nov 2, 2025

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on beh...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2024, TADAWUL:4163's revenue was 6.45 billion, an increase of 12.36% compared to the previous year's 5.74 billion. Earnings were 370.11 million, an increase of 12.42%.